<- Go home

Added to YB: 2021-09-06

Pitch date: 2021-09-06

INSM [bullish]

Insmed Incorporated

+591.26%

current return

Author Info

No bio for this author

Company Info

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Market Cap

$42.0B

Pitch Price

$28.50

Price Target

N/A

Dividend

N/A

EV/EBITDA

-43.68

P/E

-31.68

EV/Sales

91.89

Sector

Biotechnology

Category

N/A

Show full summary:
INSMED INC INSM

A summary for this pitch has not been created yet.

Read full article (0 min)